Consistently, in a cohort of patients with biopsy-proven NAFLD, hepatic IGF-1 messenger RNA (mRNA) levels were significantly decreased in patients with NASH compared to those with simple steatosis, and inversely associated with the degrees of hepatic steatosis and inflammation [142]. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.